PFE241101P33500
- 5.00
- +0.25+5.26%
Pfizer Newsroom
Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying?
Thursday, Halloween Market Falls in Scary Reaction to Earnings | Wall Street Today
Pfizer Options Spot-On: On October 31st, 97,100 Contracts Were Traded, With 3.15 Million Open Interest
Pfizer & Subsidiary Sued Over Alleged Sickle Cell Drug Side Effects
Zacks Investment Ideas Feature Highlights: Pfizer, Philip Morris and Tenet Healthcare
Halloween Market Falls, Scared of Meta and Microsoft CapEx | Live Stock
A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $31 to $33
Pfizer Inc. Just Beat EPS By 161%: Here's What Analysts Think Will Happen Next
Results: Pfizer Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think
Market Flips and Falls as Meta and MSTR Fall After Earnings | Wall Street Today
Pfizer Options Spot-On: On October 30th, 141.61K Contracts Were Traded, With 3.1 Million Open Interest
23 S&P 500 Stocks That Pay Huge Dividends
CNBC Halftime Report Final Trades: Dell Technologies, Leidos, Pfizer, The Trade Desk
Pfizer Boasts Over 30% Increase in Q3 Revenues Against Previous Year
Market Climbs, SMCI Auditors Allege Mischief on Mischief Night | Live Stock
Pfizer Surpasses Q3 Expectations With Strong Earnings and Revenue Surge
Stock To Trade: Pfizer, Trump Media, Bitcoin, and More
A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $30 to $36
Daily short sale tracking: Trump Media & Technology's short volume increased by 14 million, with a short sale ratio of 15%